Melanie Gloria is COO at Immunovant, Inc. (IMVT). They have made 8 open-market trades across 1 company since 2025, most recently 2026-10-07.
CIK 0001973838
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IMVT | 217,060 | $5.8M |
| SLRN | 130,286 | $296K |
| Total | $6.1M |
Shares reported on the most recent Form 4, priced at the 2026-10-09 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMVT | SELL | 2026-10-07 | 2026-10-09 | $32.06 | $72K | — | — | — |
| IMVT | SELL | 2026-08-20 | 2026-08-21 | $44.16 | $135K | -10.3% | -15.6% | — |
| IMVT | SELL | 2026-07-08 | 2026-07-10 | $39.55 | $81K | +3.2% | +5.1% | -20.1% |
| IMVT | SELL | 2026-06-26 | 2026-06-26 | $38.31 | $679K | +6.4% | +3.8% | -11.9% |
| IMVT | SELL | 2026-05-20 | 2026-05-22 | $32.45 | $101K | -6.5% | +8.9% | +26.8% |
| IMVT | SELL | 2026-04-08 | 2026-04-10 | $24.83 | $217K | +20.7% | +19.0% | +68.2% |
| IMVT | SELL | 2026-02-25 | 2026-02-27 | $27.85 | $90K | -5.7% | -13.1% | +23.6% |
| IMVT | SELL | 2025-11-20 | 2025-11-21 | $23.62 | $596K | +1.7% | +22.2% | +17.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.